|
Factor
|
Standardized Coefficient (Beta)
|
P Value
|
|---|
|
Polycystic Kidney Disease
|
0.062
|
<0.001
|
|
Pre-Dialysis EPO use
|
0.123
|
<0.001
|
|
Serum Albumin
|
0.157
|
<0.001
|
|
Male
|
0.113
|
<0.001
|
|
Age (per year)
|
0.034
|
<0.001
|
|
Year of First ESRD Service
|
0.06
|
<0.001
|
|
Smoking
|
0.015
|
0.007
|
|
Ischemic Heart Disease
|
0.013
|
0.027
|
|
Hemodialysis (vs. peritoneal dialysis)
|
-0.076
|
<0.001
|
|
Serum Creatinine (mg/dl)
|
-0.296
|
<0.001
|
|
Congestive Heart Failure
|
-0.029
|
<0.001
|
- Dialysis modality was obtained from the Medical Evidence form (HCFA 2728), and was therefore only available for patients who started on ESRD therapy on or after 1995. Only variables that were significant in univariate analysis are shown.
